Related Experiment Video
Updated: Sep 20, 2025

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects
Zhengming Tian1, Xunming Ji1,2, Jia Liu1
1Laboratory of Brain Disorders, Beijing Institute of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Capital Medical University, Beijing 100069, China.
Insights
Vascular cognitive impairment and dementia (VCID) is linked to chronic brain hypoperfusion. Neuroinflammation triggered by this condition plays a key role in VCID development, offering new treatment targets.
Area of Science:
- Neuroscience
- Immunology
- Cerebrovascular Medicine
Background:
- Vascular cognitive impairment and dementia (VCID) is the second leading cause of dementia globally.
- VCID results from chronic low brain perfusion, leading to cognitive dysfunction.
- Current VCID treatment strategies are limited due to ambiguous classification and diagnostic criteria.
Purpose of the Study:
- To explore neuroinflammation mechanisms in VCID induced by ischemia and hypoxia.
- To emphasize the role of neuroinflammation in VCID development.
- To provide insights for VCID prevention and treatment.
Main Methods:
- Review of existing literature on neuroinflammation in VCID.
- Analysis of immune cells, mediators, and signaling pathways involved.
- Focus on ischemia and hypoxia induced by chronic hypoperfusion.
Main Results:
- Chronic hypoperfusion induces ischemia and hypoxia, overactivating neuroinflammation.
- Neuroinflammation contributes to apoptosis and blood-brain barrier damage in VCID.
- Immune responses are critical in the pathogenesis of VCID.
Conclusions:
- Neuroinflammation is a significant factor in the development and progression of VCID.
- Understanding neuroinflammatory pathways offers potential therapeutic targets for VCID.
- Further research into immune mechanisms can guide novel treatment strategies for VCID.
Abstract:
Vascular cognitive impairment and dementia (VCID) is a major heterogeneous brain disease caused by multiple factors, and it is the second most common type of dementia in the world. It is caused by long-term chronic low perfusion in the whole brain or local brain area, and it eventually develops into severe cognitive dysfunction syndrome. Because of the disease's ambiguous classification and diagnostic criteria, there is no clear treatment strategy for VCID, and the association between cerebrovascular pathology and cognitive impairment is controversial. Neuroinflammation is an immunological cascade reaction mediated by glial cells in the central nervous system where innate immunity resides. Inflammatory reactions could be triggered by various damaging events, including hypoxia, ischemia, and infection. Long-term chronic hypoperfusion-induced ischemia and hypoxia can overactivate neuroinflammation, causing apoptosis, blood-brain barrier damage and other pathological changes, triggering or aggravating the occurrence and development of VCID. In this review, we will explore the mechanisms of neuroinflammation induced by ischemia and hypoxia caused by chronic hypoperfusion and emphasize the important role of neuroinflammation in the development of VCID from the perspective of immune cells, immune mediators and immune signaling pathways, so as to provide valuable ideas for the prevention and treatment of the disease.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Dementia
The progression of dementia is generally gradual....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Inflammatory Response I: Vascular and Cellular

